Goldman Sachs Adjusts Price Target on Merck & Company to $145 From $144
Merck & Co Analyst Ratings
Morgan Stanley Adjusts Price Target on Merck to $134 From $132
Merck & Co Analyst Ratings
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating
Merck & Co Analyst Ratings
Redburn Atlantic Adjusts Price Target on Merck to $148 From $142
Merck & Co Analyst Ratings
Jefferies Adjusts Merck & Company Price Target to $150 From $145
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating
Merck & Co Analyst Ratings
Merck & Co Analyst Ratings
Merck & Company (MRK) Receives a Buy From Cantor Fitzgerald
Merck & Co Analyst Ratings
Merck & Co Analyst Ratings
Buy Rating on Merck & Co. Affirmed by Daina Graybosch Amidst WINREVAIR's Market Potential and Efficacy
Merck & Co Analyst Ratings
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating
Merck & Co Analyst Ratings
Maintaining Hold on Merck & Co. Amidst Sotatercept's Promising Developments and Revised Sales Projections